Changchun High-Tech Industries (Group) Inc.
000661.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$29.33B
Close$
$35.77
48.2% downside
Current Fair Value
48.2% downsideOvervalued by 48.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $29.33 Billion |
|---|---|
| Enterprise Value | $28.95 Billion |
| Dividend Yield | $0.16 (0.22%) |
| Earnings per Share | $0.39 |
| Beta | 0.43 |
| Outstanding Shares | 401,714,412 |
Return
| Return on Equity | -1.57% |
|---|---|
| Return on Assets | -1.15% |
| Return on Invested Capital | -1.47% |
Valuation & Multiples
| P/E Ratio | -128.39 |
|---|---|
| PEG | 210.9 |
| Price to Sales | 2.56 |
| Price to Book Ratio | 1.11 |
| Enterprise Value to Revenue | 2.63 |
| Enterprise Value to EBIT | -76.19 |
| Enterprise Value to Net Income | -83 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Changchun High-Tech Industries (Group) Inc.
11,547 employees
CEO: Lei Jin Changchun High-Tech Industries (Group) Inc., operating with its various subsidiaries, is primarily involved in the production and distribution of biopharmaceutical products and traditional Chinese medicines across the Chinese market. Add...